Malaria Vaccines – Paving the Way for a Malaria-free World

1. Malaria VaccinesMarket - Size, Share, Emerging Trends, Outlook, and Opportunity Analysis, 2016 – 2024 Global Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine), Agent (Plasmodium Falciparum, Plasmodium Vivax), Distribution Channel (Hospitals, Clinics, Community Centers), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024 Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led to increased inclination of various healthcare agencies towards addressing this major malady. Global non-profit organizations such as the Melinda Gates Foundation and PATH are working towards developing preventive measures and saving lives of many in the malaria affected regions. Africa accounts for the largest number of malaria cases and hence, this region is the primary target of launching the first malaria vaccine developed by GlaxoSmithKline plc. Mosquirix received EU approval in 2015 and is presently being examined in Africa as a pilot study. “The Global Malaria Vaccines Market is expected to be valued at US$ 8.5 million in 2016 and is expected to witness a CAGR of 102.8% during the forecast period (2016 – 2024).” Download PDF Brochure of Market Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/37 People in Africa use insecticide-treated mosquito nets and indoor-insecticide spraying for prevention against malarial vectors. Use of insecticide-treated mosquito nets in Africa increased by 80% during 2010-2015 (WHO). Moreover, a number of mosquito repellent products (patches, creams, coils, mats, liquids, etc.) are marketed globally. Besides, non-profit organizations provide cheap and often free treatment facilities to the malarial affected population in Africa. Also, GSK has pledged to sell the vaccines at a much lower cost forgoing its huge profit margins to support the global malaria eradication programs. Furthermore, with more malarial vaccines under research pipeline, the malaria vaccines market is poised for significant growth in near future.

2. Key Vendors of Malaria Vaccines Market: Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc. Browse more about the Malaria Vaccines Market Study: https://www.coherentmarketinsights.com/market-insight/malaria-vaccines-market-37 Report includes chapters which deeply display the following deliverable about industry: • Malaria Vaccines Market Research Objective and Assumption • Malaria Vaccines Market Preview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Malaria Vaccines Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Malaria Vaccines Market, By Regions • Malaria Vaccines Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Malaria Vaccines Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Malaria Vaccines Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Malaria Vaccines Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion.

3. Table of Contents of Malaria Vaccines Market Report: 1. Research Objective and assumption 2. Market Purview 3. Market Dynamics, Regulations, and Trends Analysis 4. Malaria Vaccines Market, By Advanced Water Meters, 2016 - 2024 (USD Million) 5. Malaria Vaccines Market, By Service, 2016 - 2024 (USD Million) 6. Malaria Vaccines Market, By Solution, 2016 - 2024 (USD Million) 7. Malaria Vaccines Market, By Regions, 2016 - 2024 (USD Million) 8. Competitive Landscape Ask for Discount before Buying: https://www.coherentmarketinsights.com/insight/request-discount/37 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com